Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Dieplinger

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 23, 2008
Utility of the PFA-100 instrument and the novel multiplate analyzer for the assessment of aspirin and clopidogrel effects on platelet function in patients with cardiovascular diseaseThomas Mueller, Benjamin Dieplinger, Werner Poelz, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 4, 2009
Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) studyBenjamin Dieplinger, Meinhard Haltmayer, Werner Poelz, et al.
Clinical Chemistry|April 15, 2006
Increased pregnancy-associated plasma protein-A as a marker for peripheral atherosclerosis: results from the Linz Peripheral Arterial Disease StudyThomas Mueller, Benjamin Dieplinger, Werner Poelz, et al.
Vascular Medicine (London, England)|April 13, 2016
Mortality rates at 10 years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial diseaseThomas Mueller, Franz Hinterreiter, Werner Poelz, et al.
Clinical Chemistry|October 15, 2005
Capability of B-type natriuretic peptide (BNP) and amino-terminal proBNP as indicators of cardiac structural disease in asymptomatic patients with systemic arterial hypertensionThomas Mueller, Alfons Gegenhuber, Benjamin Dieplinger, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 6, 2011
Proguanylin and prouroguanylin--assay evaluation and clinical analyte characterizationGerhard Kaar, Benjamin Dieplinger, Christian Gabriel, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 19, 2018
Evaluation of sex-specific cut-off values of high-sensitivity cardiac troponin I and T assays in an emergency department setting - Results from the Linz Troponin (LITROP) studyThomas Mueller, Margot Egger, Evi Peer, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 21, 2015
Analytical and clinical evaluation of a rapid quantitative lateral flow immunoassay for measurement of soluble ST2 in human plasmaBenjamin Dieplinger, Margot Egger, Alfons Gegenhuber, et al.
Clinical Chemistry and Laboratory Medicine|September 25, 2004
Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samplesThomas Mueller, Alfons Gegenhuber, Benjamin Dieplinger, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 8, 2015
Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseasesThomas Mueller, Isabella Leitner, Margot Egger, et al.
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 23, 2008
Utility of the PFA-100 instrument and the novel multiplate analyzer for the assessment of aspirin and clopidogrel effects on platelet function in patients with cardiovascular diseaseThomas Mueller, Benjamin Dieplinger, Werner Poelz, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 4, 2009
Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) studyBenjamin Dieplinger, Meinhard Haltmayer, Werner Poelz, et al.
Clinical Chemistry|April 15, 2006
Increased pregnancy-associated plasma protein-A as a marker for peripheral atherosclerosis: results from the Linz Peripheral Arterial Disease StudyThomas Mueller, Benjamin Dieplinger, Werner Poelz, et al.
Vascular Medicine (London, England)|April 13, 2016
Mortality rates at 10 years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial diseaseThomas Mueller, Franz Hinterreiter, Werner Poelz, et al.
Clinical Chemistry|October 15, 2005
Capability of B-type natriuretic peptide (BNP) and amino-terminal proBNP as indicators of cardiac structural disease in asymptomatic patients with systemic arterial hypertensionThomas Mueller, Alfons Gegenhuber, Benjamin Dieplinger, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 6, 2011
Proguanylin and prouroguanylin--assay evaluation and clinical analyte characterizationGerhard Kaar, Benjamin Dieplinger, Christian Gabriel, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 19, 2018
Evaluation of sex-specific cut-off values of high-sensitivity cardiac troponin I and T assays in an emergency department setting - Results from the Linz Troponin (LITROP) studyThomas Mueller, Margot Egger, Evi Peer, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 21, 2015
Analytical and clinical evaluation of a rapid quantitative lateral flow immunoassay for measurement of soluble ST2 in human plasmaBenjamin Dieplinger, Margot Egger, Alfons Gegenhuber, et al.
Clinical Chemistry and Laboratory Medicine|September 25, 2004
Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samplesThomas Mueller, Alfons Gegenhuber, Benjamin Dieplinger, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 8, 2015
Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseasesThomas Mueller, Isabella Leitner, Margot Egger, et al.
Pageof 11